Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2026-02-26 @ 8:11 PM
Study NCT ID:
NCT00943592
Status:
COMPLETED
Last Update Posted:
2014-02-27
First Post:
2009-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-20
First Submit QC Date:
None
Study First Post Date:
2009-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-17
Results First Submit QC Date:
None
Results First Post Date:
2014-02-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-09
Last Update Post Date:
2014-02-27
Last Update Post Date Type:
ESTIMATED